Funder: National Institutes of Health
Due Dates: October 1, 2026 (Estimated Application Due Date)
Funding Amounts: $700,000 total program funding; 1 expected award; duration and ceiling not specified
Summary: Supports the collection and analysis of data from clinical trials involving isolated human islets as a treatment for diabetes, with the aim to inform future research and public health.
Key Information: This is a forecasted opportunity; applications are not yet being solicited.